Guideline
- Page Path
-
- HOME
- ARTICLE CATEGORY
- Guideline
- Guideline
- 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
- Clin Mol Hepatol. 2022;28(4):583-705. Published online October 1, 2022
-
View: 4146 Download: 385 Citations: 28
- KASL clinical practice guidelines for management of chronic hepatitis B
- Clin Mol Hepatol. 2022;28(2):276-331. Published online April 1, 2022
-
DOI: https://doi.org/10.3350/cmh.2022.0084 Correction in: Clin Mol Hepatol 2022;28(4):940
-
View: 6835 Download: 463 Citations: 20
- KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
- Seong Hee Kang, Hye Won Lee, Jeong-Ju Yoo, Yuri Cho, Seung Up Kim, Tae Hee Lee, Byoung Kuk Jang, Sang Gyune Kim, Sang Bong Ahn, Haeryoung Kim, Dae Won Jun, Joon-Il Choi, Do Seon Song, Won Kim, Soung Won Jeong, Moon Young Kim, Hong Koh, Sujin Jeong, Jin-Woo Lee, Yong Kyun Cho
- Clin Mol Hepatol. 2021;27(3):363-401. Published online June 22, 2021
-
View: 12930 Download: 1,088 Citations: 99
- KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications
- Clin Mol Hepatol. 2020;26(2):83-127. Published online January 10, 2020
-
View: 17470 Download: 1,258 Citations: 52
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
First decision
09 Days
Publication after acceptance
07 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2021-2023)
|
|||||||
